Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept

A biosimilar is a biological medicinal product that is comparable to a reference medicinal product in terms of quality, safety, and efficacy. SB4 was developed as a biosimilar to Enbrel® (etanercept) and was approved as Benepali®, the first biosimilar of etanercept licensed in the European Union (EU...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Ick Hyun, Lee, Nayoung, Song, Dami, Jung, Seong Young, Bou-Assaf, George, Sosic, Zoran, Zhang, Wei, Lyubarskaya, Yelena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968139/
https://www.ncbi.nlm.nih.gov/pubmed/27246928
http://dx.doi.org/10.1080/19420862.2016.1193659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968139/
https://www.ncbi.nlm.nih.gov/pubmed/27246928
http://dx.doi.org/10.1080/19420862.2016.1193659

Ejemplares similares